StockViz
Share URL
Embed chart view
-
Export .csv
-
Download image
-
Copy link
-
Embed code
StockViz
RANKINGS
China National Accord Medicines Corporation Ltd.
Shenzhen Stock Exchange:000028.SZ
Sector
Location
Market Cap
USD 1.81 B
Share Price
USD 3.49
Avg Daily Volume
3,144,601
Change (1 day)
0.04%
Change (1 year)
-20.08%
Change (YTD)
-12.94%
China National Accord Medicines Corporation Ltd. Debt to Equity Ratio for the year ending December 31, 2024: 0.25
China National Accord Medicines Corporation Ltd. Debt to Equity Ratio is 0.25 for the year ending December 31, 2024, a -68.55% change year over year. Debt to equity ratio represents the financing from debt versus equity. Higher ratio indicates more debt reliance, suggesting potential risk.
-
China National Accord Medicines Corporation Ltd. Debt to Equity Ratio for the year ending December 31, 2023 was 0.79, a 261.94% change year over year.
-
China National Accord Medicines Corporation Ltd. Debt to Equity Ratio for the year ending December 31, 2022 was 0.22, a -22.94% change year over year.
-
China National Accord Medicines Corporation Ltd. Debt to Equity Ratio for the year ending December 31, 2021 was 0.28, a 6.87% change year over year.
-
China National Accord Medicines Corporation Ltd. Debt to Equity Ratio for the year ending December 31, 2020 was 0.26, a 4.83% change year over year.
Competitors
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.26
0874.HK
-0.00
-0.10%
Galenica AG
USD 111.21
GALE.SW
-0.56
-0.50%
Eli Lilly and Company
USD 772.87
LLY
-7.80
-1.00%
Johnson & Johnson
USD 155.27
JNJ
-0.74
-0.47%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
McKesson Corporation
USD 735.33
MCK
+16.03
2.23%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
Elevance Health Inc.
USD 346.88
ELV
-0.96
-0.28%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
Cencora, Inc.
USD 302.50
COR
+6.27
2.12%
Wal-Mart de México, S.A.B. de C.V.
USD 3.18
WALMEX.MX
-0.09
-2.63%
Key Data
| Date | Debt to Equity Ratio | Quick Ratio | Current Ratio | Interest Coverage Ratio |
|---|
Competitors
Guangzhou Baiyunshan Pharmaceutical Holdings Company Limited
USD 2.26
0874.HK
-0.00
-0.10%
Galenica AG
USD 111.21
GALE.SW
-0.56
-0.50%
Eli Lilly and Company
USD 772.87
LLY
-7.80
-1.00%
Johnson & Johnson
USD 155.27
JNJ
-0.74
-0.47%
AbbVie Inc.
USD 187.63
ABBV
-1.65
-0.87%
Roche Holding AG
USD 342.25
RO.SW
-5.82
-1.67%
AstraZeneca PLC
USD 138.95
AZN.L
-2.01
-1.43%
Merck & Co., Inc.
USD 80.90
MRK
-0.03
-0.04%
Amgen Inc.
USD 292.95
AMGN
-5.29
-1.77%
Pfizer Inc.
USD 25.24
PFE
-0.14
-0.55%
Gilead Sciences, Inc.
USD 111.78
GILD
+0.03
0.03%
Sanofi
USD 96.52
SAN.PA
-1.52
-1.55%
Bristol-Myers Squibb Company
USD 46.49
BMY
-0.43
-0.92%
McKesson Corporation
USD 735.33
MCK
+16.03
2.23%
Chugai Pharmaceutical Co., Ltd.
USD 47.25
4519.T
-1.65
-3.37%
Elevance Health Inc.
USD 346.88
ELV
-0.96
-0.28%
GSK plc
USD 18.98
GSK.L
-0.18
-0.96%
Regeneron Pharmaceuticals, Inc.
USD 538.11
REGN
-9.25
-1.69%
Cencora, Inc.
USD 302.50
COR
+6.27
2.12%
Wal-Mart de México, S.A.B. de C.V.
USD 3.18
WALMEX.MX
-0.09
-2.63%